- VIVO Cannabis (VIVO) adds Assuage Suppositories to online medical marketplace
- Assuage™ suppositories for vaginal and rectal use are available in two formulations
- Assuage means to ‘ease, or make an unpleasant feeling less intense’, and these suppositories were designed keeping patient comfort and efficacy in mind
- Partnering with Canna Farms ensures broad access of this unique dosage format for tens of thousands of patients
- These are exclusively available through the Canna Farms e-commerce medical marketplace for Canadian medical clients
- VIVO Cannabis Inc. (VIVO) is trading at C$0.08 at 11:39 am EST
VIVO Cannabis (VIVO) in partnership with Cicatrix Labs is offering Assuage™ vaginal and rectal suppositories on VIVO’s Canna Farms e-commerce marketplace.
“In keeping with our laser focused medical strategy, we are extremely proud to be the first legal medical marketplace in Canada to launch the broadest range of suppositories available to all Canadian patients,” commented Ray Laflamme, Canna Farms’ Co-Founder and VIVO’s Chief Executive Officer.
“We’ve listened to our patients and advocacy groups, and we have recognized an unmet need for this specialized dosage format to support various women’s health conditions gastrointestinal health conditions affecting both men and women,” added Laflamme.
Assuage™ suppositories for vaginal and rectal use are available in two formulations: 50 mg cannabidiol (CBD), and 1:3 formulation of 10 mg tetrahydrocannabinol (THC) and 30 mg CBD, with 8 suppositories per tin package.
“Assuage means to ‘ease, or make an unpleasant feeling less intense’, and these suppositories were designed keeping patient comfort and efficacy in mind for those unable to obtain relief with oral or inhaled cannabis,” commented Sarah Roberts, RPh, President and Founder of Cicatrix Labs.
“Patients no longer have to purchase suppositories from the illegal market or make their own. Partnering with Canna Farms ensures broad access of this unique dosage format for tens of thousands of patients,” concluded Roberts.
VIVO is committed to its patient-first approach ensuring access to novel cannabinoid-based formulations.
These newly launched Assuage vaginal and rectal suppositories are exclusively available through the Canna Farms e-commerce medical marketplace for Canadian medical clients.
VIVO Cannabis™ is recognized for trusted, premium cannabis products and services. It holds production and sales licences from Health Canada and operates world-class cultivation facilities.
Cicatrix Labs is a pharmacist-founded manufacturer of unique cannabinoid-infused products including topicals and suppositories.
Cicatrix Labs offers an in-house line of personal care products to Licensed Producers and Medical License holders as well as custom white-labeled products.
VIVO Cannabis Inc. (VIVO) is trading at C$0.08 at 11:39 am EST.
